Multiplex Molecular Point‑of‑Care Test for Syndromic Infectious Diseases

다국어 초록 (Multilingual Abstract)

Point-of-care (POC) molecular diagnostics for clinical microbiology and virology has primarily focused on the detection of a single pathogen. More recently, it has transitioned into a comprehensive syndromic approach that employs multiplex capabilities, including the simultaneous detection of two or more pathogens. Multiplex POC tests provide higher accuracy to for actionable decisionmaking in critical care, which leads to pathogen-specific treatment and standardized usages of antibiotics that help prevent unnecessary processes. In addition, these tests can be simple enough to operate at the primary care level and in remote settings where there is no laboratory infrastructure. This review focuses on state-of-the-art multiplexed molecular point-of-care tests (POCT) for infectious diseases and efforts to overcome their limitations, especially related to inadequate throughput for the identification of syndromic diseases. We also discuss promising and imperative clinical POC approaches, as well as the possible hurdles of their practical applications as front-line diagnostic tests.

참고문헌 (Reference)

1 You, M., "Ultrafast photonic PCR based on photothermal nanomaterials" 38 : 637-649, 2020

2 Cai, Q., "Ultra-fast, sensitive and quantitative on-chip detection of group B streptococci in clinical samples" 192 : 220-225, 2019

3 Bissonnette, L., "The GenePOC platform, a rational solution for extreme point-of-care testing" 7 : 94-, 2016

4 Mylonakis, E., "T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial" 60 : 892-899, 2015

5 Weissensteiner, T., "Strategy for controlling preferential amplifcation and avoiding false negatives in PCR typing" 21 : 1102-1108, 1996

6 Yeh, E.C., "Self-powered integrated microfuidic point-ofcare low-cost enabling (SIMPLE) chip" 3 : e1501645-, 2017

7 Tyler, J., "Real-time, personalized medicine through wearable sensors and dynamic predictive modeling:a new paradigm for clinical medicine" 20 : 17-25, 2020

8 Son, J. H., "Rapid optical cavity PCR" 5 : 167-174, 2016

9 Park, K.S., "Rapid identifcation of health care-associated infections with an integrated fuorescence anisotropy system" 2 : e1600300-, 2016

10 Wang, X., "Rapid and sensitive detection of COVID-19using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER" 65 : 1436-1439, 2020

11 Van Nguyen, J.C., "Prospective evaluation of the Alere i Infuenza A&B nucleic acid amplifcation versus Xpert Flu/RSV" 85 : 19-22, 2016

12 Kozel, T. R., "Point-of-care testing for infectious diseases: past, present, and future" 55 : 2313-2320, 2017

13 Mauk, M. G., "Point-of-care molecular test for Zika infection" 41 : 25-27, 2017

14 Dien Bard, J., "Point-counterpoint: meningitis/encephalitis syndromic testing in the clinical laboratory" 56 : e00018-18, 2018

15 Schreckenberger, P. C., "Point-counterpoint: large multiplex PCR panels should be frst-line tests for detection of respiratory and intestinal pathogens" 53 : 3110-3115, 2015

16 Gaydos, C. A., "Point-by-point progress: gonorrhea point of care tests" 20 : 803-813, 2020

17 Lee, J. H., "Plasmonic photothermal gold bipyramid nanoreactors for ultrafast real-time bioassays" 139 : 8054-8057, 2017

18 Garzon, V., "Personalized medicine for antibiotics: the role of nanobiosensors in therapeutic drug monitoring" 10 : 147-, 2020

19 Jensen, S. O., "Personalized medicine and infectious disease management" 25 : 875-876, 2017

20 Lee, S.H., "One-pot reverse transcriptional loop-mediated isothermal amplifcation (RT-LAMP) for detecting MERS-CoV" 7 : 2166-, 2016

21 de la Fuente-Nunez, C., "Next-generation precision antimicrobials: towards personalized treatment of infectious diseases" 37 : 95-102, 2017

22 Lee, Y., "Nanoplasmonic on-chip PCR for rapid precision molecular diagnostics" 12 : 12533-12540, 2020

23 Zhu, X., "Multiplex reverse transcription loop-mediated isothermal amplifcation combined with nanoparticle-based lateral fow biosensor for the diagnosis of COVID-19" 166 : 112437-, 2020

24 Teengam, P., "Multiplex paper-based colorimetric DNA sensor using pyrrolidinyl peptide nucleic acid-induced AgNPs aggregation for detecting MERS-CoV, MTB, and HPV oligonucleotides" 89 : 5428-5435, 2017

25 Gibson, J., "Multi-center evaluation of the cobas((R))Liat((R)) Infuenza A/B & RSV assay for rapid point of care diagnosis" 95 : 5-9, 2017

26 Young, S., "Molecular point-of-care testing for infuenza A/B and respiratory syncytial virus: comparison of workfow parameters for the ID Now and cobas Liat systems" 73 : 328-334, 2020

27 Emmadi, R., "Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays" 13 : 583-604, 2011

28 Senescau, A., "Innovative DendrisChips((R)) Technology for a syndromic approach of in vitro diagnosis: application to the respiratory infectious diseases" 8 : 77-, 2018

29 Bissonnette, L., "Infectious disease management through point-of-care personalized medicine molecular diagnostic technologies" 2 : 50-70, 2012

30 Kaufmann, S. H. E., "Host-directed therapies for bacterial and viral infections" 17 : 35-56, 2018

31 Chen, B., "Good laboratory practices for molecular genetic testing for heritable diseases and conditions" 58 : 1-37, 2009

32 Trinh, K. T. L., "Fabrication of a foldable all-in-one point-of-care molecular diagnostic microdevice for the facile identifcation of multiple pathogens" 314 : 128057-, 2020

33 Van Der Pol, "Evaluation of the performance of a pointof-care test for chlamydia and gonorrhea" 3 : e204819-, 2020

34 Sexton, D. J., "Evaluation of a new T2 Magnetic Resonance assay for rapid detection of emergent fungal pathogen Candida auris on clinical skin swab samples" 61 : 786-790, 2018

35 Suea-Ngam, A., "Enzyme-assisted nucleic acid detection for infectious disease diagnostics: moving toward the point-of-care" 5 : 2701-2723, 2020

36 Woolley, C. F., "Emerging technologies for biomedical analysis" 139 : 2277-2288, 2014

37 Duf, S., "Economic analysis of rapid multiplex polymerase chain reaction testing for meningitis/encephalitis in pediatric patients" 13 : 617-629, 2018

38 Qiu, G., "Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection" 14 : 5268-5277, 2020

39 Landry, M.L., "Diagnostic tests for infuenza infection" 23 : 91-97, 2011

40 Vetter, P., "Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach" 26 : 706-712, 2020

41 신지훈, "Development of Molecular Diagnosis Using Multiplex Real-Time PCR and T4 Phage Internal Control to Simultaneously Detect Cryptosporidium parvum, Giardia lamblia, and Cyclospora cayetanensis from Human Stool Samples" 대한기생충학ㆍ열대의학회 56 (56): 419-427, 2018

42 Barrientos-Duran, A., "Detection of sexually transmitted disease-causing pathogens from direct clinical specimens with the multiplex PCR-based STD Direct Flow Chip Kit" 39 : 235-241, 2020

43 Kanwar, N., "Comparison of the ID now infuenza A & B 2, Cobas Infuenza A/B, and Xpert Xpress fu point-of-care nucleic acid amplifcation tests for infuenza A/B virus detection in children" 58 : e01611-19, 2020

44 Banerjee, D., "Comparison of six sample-to-answer infuenza A/B and respiratory syncytial virus nucleic acid amplifcation assays using respiratory specimens from children" 56 : e00930-18, 2018

45 Wahrenbrock, M.G., "Comparison of cepheid Xpert Flu/RSV XC and BioFire FilmArray for detection of infuenza a, infuenza b, and respiratory syncytial virus" 54 : 1902-1903, 2016

46 Abbott, A. N., "Clinical impact of multiplex syndromic panels in the diagnosis of bloodstream, gastrointestinal, respiratory, and central nervous system infections" 39 : 133-142, 2017

47 Mitamura, K., "Clinical evaluation of ID NOW infuenza A & B 2, a rapid infuenza virus detection kit using isothermal nucleic acid amplifcation technology—a comparison with currently available tests" 26 : 216-221, 2020

48 Chen, J., "Capillary-based integrated digital PCR in picoliter droplets" 18 : 412-421, 2018

49 Broughton, J.P., "CRISPR-Cas12-based detection of SARSCoV-2" 38 : 870-874, 2020

50 Lee, S. H., "Bubble-free rapid microfuidic PCR" 126 : 725-733, 2019

51 Demeke Teklemariam, A., "Biosensor and molecular-based methods for the detection of human coronaviruses: a review" 54 : 101662-, 2020

52 Zhou, J., "Biomimetic nanotechnology toward personalized vaccines" 32 : e1901255-, 2020

53 Caliendo, A.M., "Better tests, better care: improved diagnostics for infectious diseases" 57 (57): S139-S170, 2013

54 Paul, R., "Advances in point-of-care nucleic acid extraction technologies for rapid diagnosis of human and plant diseases" 169 : 112592-, 2020

55 Yin, J., "A “sample-in-multiplex-digital-answer-out” chip for fast detection of pathogens" 20 : 979-986, 2020

56 Shu, B., "A sample-to-answer, real-time convective polymerase chain reaction system for point-of-care diagnostics" 97 : 360-368, 2017

57 Mack, M. R., "A precision medicine-based strategy for a severe adverse drug reaction" 26 : 167-168, 2020

58 Rodriguez, N. M., "A fully integrated paperfuidic molecular diagnostic chip for the extraction, amplifcation, and detection of nucleic acids from clinical samples" 16 : 753-763, 2016

59 Li, B., "A digital PCR system based on the thermal cycled chip with multi helix winding capillary" 10 : 17824-, 2020